| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.007 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.007 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |